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Abstract
Background: It was previously shown that K+ secretion by strial marginal cell epithelium is under
the control of G-protein coupled receptors of the P2Y family in the apical membrane. Receptor
activation by uracil nucleotides (P2Y2, P2Y4 or P2Y6) leads to a decrease in the electrogenic K+
secretion. The present study was conducted to determine the subtype of the functional purinergic
receptor in gerbil stria vascularis, to test if receptor activation leads to elevation of intracellular
[Ca2+] and to test if the response to these receptors undergoes desensitization.
Results: The transepithelial short circuit current (Isc) represents electrogenic K+ secretion and
was found to be decreased by uridine 5'-triphosphate (UTP), adenosine 5'-triphosphate (ATP) and
diadenosine tetraphosphate (Ap4A) but not uridine 5'-diphosphate (UDP) at the apical membrane
of marginal cells of the gerbil stria vascularis. The potencies of these agonists were consistent with
rodent P2Y4 and P2Y2 but not P2Y6 receptors. Activation caused a biphasic increase in intracellular
[Ca2+] that could be partially blocked by 2-aminoethoxy-diphenyl borate (2-APB), an inhibitor of
the IP3 receptor and store-operated channels. Suramin (100 µM) did not inhibit the effect of UTP
(1 µM). The ineffectiveness of suramin at the concentration used was consistent with P2Y4 but not
P2Y2. Transcripts for both P2Y2 and P2Y4 were found in the stria vascularis. Sustained exposure to
ATP or UTP for 15 min caused a depression of Isc that appeared to have two components but with
apparently no chronic desensitization.
Conclusion: The results support the conclusion that regulation of K+ secretion across strial
marginal cell epithelium occurs by P2Y4 receptors at the apical membrane. The apparent lack of
desensitization of the response is consistent with two processes: a rapid-onset phosphorylation of
KCNE1 channel subunit and a slower-onset of regulation by depletion of plasma membrane PIP2.
Background
A high concentration of K+ is maintained in the lumen of
the cochlea via electrogenic secretion by the strial mar-
ginal cell epithelium [1]. One pathway of regulation is the
coupling of purinergic receptors on the apical membrane
of these cells to the apical potassium channels (IKs) which
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mediate secretion [2]. These receptors are responsive to
both ATP and UTP as agonists and they were found to
exert their action via the phospholipase C – protein kinase
C intracellular signal pathway [3]. At the time of the orig-
inal investigations, the purinergic receptor field recog-
nized only 1 receptor responding to uracil nucleotides
(P2U, now P2Y2 receptor). The known members of the
mammalian metabotropic, G protein-coupled, purinergic
receptors has since grown to P2Y1, P2Y2, P2Y4, P2Y6,
P2Y11, P2Y12, P2Y13 and P2Y14 [4]. In addition to P2Y2,
both the P2Y4 and P2Y6 receptors also respond to uracil
nucleotides. On the basis of pharmacologic agonist and
antagonist profiles, P2Y6  could be distinguished from
P2Y2 and P2Y4 by the greater potency of UDP over UTP
[5,6]. The pharmacologic distinction between P2Y2 and
P2Y4  was more ambiguous and the accepted criteria
changed rapidly [7].
The question of the subtype of P2Y receptor mediating
regulation of K+ secretion by strial marginal cells has been
addressed by immunohistochemistry, which suggests the
presence of P2Y4 in the apical marginal cell membrane
[8]. However, a functional demonstration was lacking, the
time-course of activation was not investigated and an
independent demonstration of gene expression was not
available.
The present study was conducted with the goals of 1)
obtaining dose-response profiles for potentially definitive
agonists of P2Y2, P2Y4 and P2Y6 receptors; 2) refining the
profile by the use of antagonists, 3) testing for desensitiza-
tion of the response to agonist and 4) determining the
presence of transcripts for pyridine-sensitive P2Y recep-
tors. The results support the conclusion that regulation of
K+ secretion by strial marginal cells occurs by apical P2Y4
receptors.
Results
ATP perfused for 30 s at the apical side of strial marginal
cell epithelium caused a monophasic decrease in Isc (Fig.
1A), consistent with previous findings [2]. Removal of
ATP led to a recovery of Isc after an initial overshoot. Sim-
ilar responses were seen from perfusion of other agonists,
such as UTP and Ap4A (Fig. 1B &1C).
The P2Y6 agonist, UDP, was tested after removal of con-
tamination by UTP in the commercial product [6]. Con-
taminating UTP was digested by hexokinase in the
presence of glucose. The enzymatically-purified UDP pro-
duced little effect on Isc (Fig. 2).
Concentration-response curves for the purinergic agonists
are summarized in Figure 2. The potency order was UTP ≥
ATP > Ap4A >> UDP with EC50 values for UTP and ATP of
about 2.3 and 1.2 × 10-5 M. The relative potencies of the
agonists are consistent with an action on P2Y2 and/or
P2Y4 receptors.
The purinergic receptor antagonist, suramin, was tested
for effectiveness in blocking the response to apical UTP.
Suramin at 100 µM had no inhibitory effect on the action
of the agonist, UTP (Fig. 3). UTP (1 µM) caused a decrease
in Isc by 20.6 ± 5.4% in the absence of suramin and by 21.9
± 5.3% (P > 0.05, n = 5) in the presence of suramin.
Both P2Y2 and P2Y4 receptor subtypes have been reported
to undergo desensitization within 5–15 min [9,10]. Sur-
prisingly, we found that sustained exposure (15 min) of
the apical membrane to ATP led to a biphasic but sus-
tained inhibition of Isc (Fig. 4). The recovery of Isc after
removal of agonist was much slower, incomplete and
without overshoot compared to acute exposure to agonist.
Summary recordings of Isc (Ussing chamber) of strial mar- ginal cells Figure 1
Summary recordings of Isc (Ussing chamber) of strial 
marginal cells during apical perfusion of A) ATP (10-3 M; 30 
s; n = 6), B) UTP (10-4 M; 30 s; n = 7) and C) Ap4A (3 × 10-4 
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Perfusion of UTP (10 µM) for 30 s led to an increase in
intracellular [Ca2+] that had both a peak and plateau
phase and was repeatable (Fig. 5, top). Both the peak and
plateau were significantly reduced by 2-APB (75 µM) (to
26.5 ± 3.9% and 25.1 ± 4.6%; Fig. 5, middle). 2-APB is an
inhibitor of the IP3 receptor at this concentration [11,12]
and can also inhibit other transporters including store-
operated Ca2+ channels [13]. Store operated channels,
however, would not be activated under the present exper-
imental conditions, since the Ca2+ stores were not emp-
tied prior to measurement. In the absence of external
Ca2+, both the peak and plateau responses to UTP
remained but were significantly reduced (to 68.9 ± 3.0%
and 60.5 ± 4.2%; Fig. 5, bottom). The reductions, however,
were likely the result of a general decrease in intracellular
[Ca2+] seen after removal of bath Ca2+ prior to perfusion
of UTP. These findings taken together suggest that intrac-
ellular stores are the primary source of the increase in
intracellular [Ca2+] induced by UTP.
We tested for the presence of transcripts for P2Y2 and P2Y4
receptors in stria vascularis. Primers proven to recognize
gerbil P2Y2 and P2Y4 [14] were used to amplify single,
gene-specific bands in stria vascularis (Fig. 6); 301 base
pairs (bp) for P2Y2 and 447 bp for P2Y4. Controls in
which the reactions were run in the absence of reverse
transcriptase (-RT) demonstrated the absence of contribu-
tions from genomic DNA. PCR products were analyzed
for their sequence to confirm the identity of the bands.
Sequences were the same as found previously in the gerbil
vestibular labyrinth [14] (GenBank accession numbers:
P2Y2, AF313448; P2Y4, AF313447).
Discussion
Purinergic agonists control strial marginal cell K+ secre-
tion, a process observed as a transepithelial short circuit
current, Isc [1,2]. Strial marginal cells secrete K+ by a con-
stellation of transporters previously described [1]. K+ is
taken up across the basolateral membrane by the Na+, K+-
ATPase and the Na+, K+, 2Cl--cotransporter. Na+ carried
into the cell on the cotransporter is removed by the Na+-
pump and Cl- carried into the cell on the cotransporter
leaves by passive diffusion across a large Cl- conductance
in the basolateral membrane [15-17]. K+ taken up by both
the Na+-pump and cotransporter is secreted across the api-
cal membrane by diffusion through IKs channels [18],
consisting of KCNQ1 alpha subunits and KCNE1 beta reg-
ulatory subunits [19,20]. The epithelium regulates K+
secretion by a variety of signal pathways, including those
initiated by apical purinergic receptors, that converge at
the IKs channel complex [21].
The previous demonstration of control of Isc in strial mar-
ginal cell epithelium by "P2U" receptors included deter-
mination of a concentration-response to ATP and
comparative activities of other nucleotides (UTP, 2-MeS-
ATP and α, β-meth-ATP) at 1 µM [2]. Full concentration-
response curves were obtained in the present study to bet-
ter define the active subtype. The lack of response to UDP
eliminated P2Y6 as a candidate subtype [22-24]. The sim-
ilar potency of ATP and UTP is consistent with hP2Y2 [23],
rP2Y2 [22] but not hP2Y4 [6]. In fact, ATP acts as a compet-
itive antagonist at the hP2Y4 receptor [25]. However, these
results alone do not identify the strial marginal cell apical
purinergic receptor as P2Y2  since it was subsequently
found that rP2Y4 has an agonist potency sequence similar
to rat and human P2Y2 [7,25]. Since the gerbil is expected
to be more closely related to other rodents such as the rat,
than to human, our finding is consistent with the contri-
bution of P2Y4 and/or P2Y2.
The potency order of the agonists UTP, ATP, Ap4A and
UDP in regulation of Isc from strial marginal cells is the
same as for rodent P2Y4 receptors in other systems, includ-
ing cloned mouse P2Y4 [26] and gerbil vestibular dark
cells [2,27] even though the EC50 values are substantially
shifted. The absolute values of EC50's are alone not indic-
ative of receptor binding for G protein-coupled receptors,
although the relative potency remains constant. Receptor
density plays a large role in defining the response of
downstream effectors (IKs channels in this case) and dif-
ferences in density can lead to significant shifts in EC50
curves.
Transcripts for both P2Y2 and P2Y4 were found in stria vas-
cularis. The identity of the cell type(s) within the stria that
contain these transcripts is not certain from these findings
alone. Recent immunohistochemical findings show stain-
ing for the P2Y4 receptor at the apical membrane of strial
marginal cells, while the antibody for P2Y2 stained at the
basolateral region of the marginal cells and/or the inter-
mediate cells [8], consistent with the functional evidence
for apical P2Y4 shown here. The transcript expression con-
firms the immunohistochemical findings by an independ-
ent means and thereby provides an important verification
of the specificity of the P2Y antibodies used in the previ-
ous study [8].
Ap4A was found to be a potent agonist at the hP2Y2 recep-
tor [23] but much less potent than ATP at the hP2Y4 [28]
and rP2Y4 receptors [24], similar to our finding in gerbil
strial marginal cells. In spite of this similarity, uncertainty
arises in the identification of the apical receptor in strial
marginal cells as P2Y4 on this basis alone since there is
also a conflicting report from Bogdanov et al. who found
Ap4A to be equally potent as ATP at rP2Y4 receptors [7].
Suramin inhibits several P2 receptors, but it was found
recently that at a high concentration (100 µM) it can be
used to distinguish both rP2Y2 [22] and hP2Y2 [29] fromCell Communication and Signaling 2005, 3:13 http://www.biosignaling.com/content/3/1/13
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both rP2Y4 [7] and hP2Y4 [29]. This criterion applied to
the present results points to the apical P2Y purinergic
receptor in gerbil strial marginal cells as the P2Y4 subtype.
This conclusion based on function and pharmacology is
consistent with the recent report of immunohistochemi-
cal localization of P2Y4 at the apical membrane of strial
marginal cells [8]. We reported earlier that the response to
ATP is increased in the absence of divalent cations [2].
This increased effect suggests that the apical receptor is
preferentially activated by an uncomplexed form of ATP,
as in aortic endothelial cells [30].
The overshoot of Isc after removal of purinergic agonists
from the apical perfusate (Fig. 1) is most likely due to a
release of K+ accumulated in the epithelial cells during the
inhibition of secretion across the apical membrane. The
basolateral K+ uptake mechanisms continue to operate for
a time after inhibition of apical IKs channel complexes by
activation of purinergic receptors, bringing the cytosolic
K+  concentration to a level higher in electrochemical
potential above the apical bath than in the absence of ago-
nist. Upon removal of agonist this "extra pool" of K+ is
suddenly released, resulting in the observed overshoot of
Isc. The same phenomenon was reported previously [31]
when K+ secretion was first diminished by raising the api-
cal K+ concentration, thereby reducing the outward gradi-
ent across the apical cell membrane. Suddenly returning
the apical perfusate K+ concentration to the original low
level led to an overshoot of Isc, as observed with the purin-
ergic agonists.
The decrease in Isc observed in response to purinergic ago-
nists could be due a priori to a reduction of electrogenic K+
secretion but could also be accounted for by a stimulation
of secretion of Cl- or absorption of Na+. However, it was
found in a previous study that the decrease in Isc could be
completely accounted for by a decrease in K+ secretion.
Apical perfusion of 100 µM ATP lead to a decrease of Isc by
37.1 ± 3.7% and of K+ secretory flux by 22.2 ± 5.5% [3].
The peak and plateau increases in intracellular [Ca2+] dur-
ing perfusion of agonist in the presence and absence of
bath Ca2+, as well as the reduction by 2-APB, are consist-
ent with a release of Ca2+ from intracellular stores. Ikeda
et al. found a small monophasic increase in intracellular
[Ca2+] of the entire stria vascularis that could not be ana-
lyzed further [32]. The same laboratory evaluated the
purinergic response of cultured marginal cells and found
agonist-induced increases in intracellular [Ca2+] that were
not reduced upon removal of Ca2+ from the bath [33].
Those cells were derived from guinea pig, the responses
were monophasic and UTP was not tested as agonist.
The apparent absence of desensitization (Fig. 4) was a sur-
prising finding in view of reports of rapid desensitization
of both cloned P2Y2 and cloned P2Y4 purinergic receptors
[9,10]. Desensitization has typically been observed as a
decrease of inositol phosphate production and/or
cytosolic Ca2+ increase, either directly [34,35] or via the
effect of Ca2+  on transepithelial anion secretion [36].
Since the sustained response to UTP (Figure 4) is biphasic,
it therefore may represent the summation of at least 2
processes.
Summary of relative decrease in Isc Figure 3
Summary of relative decrease in Isc (vibrating probe) 
caused by UTP (1 µM) in the absence or presence of suramin 
(100 µM).
Concentration-response curves for inhibition of Isc Figure 2
Concentration-response curves for inhibition of Isc 
(Ussing chamber) by P2 agonists. Mean ± SEM, n = 4 to 7 for 
each point. Data fit to Hill equation; fit parameters are given 
in the text.Cell Communication and Signaling 2005, 3:13 http://www.biosignaling.com/content/3/1/13
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The question arises as to the basis for the observed sus-
tained decrease in IKs. Possible explanations include: 1)
The P2Y4 receptor desensitizes several minutes after the
onset of agonist, but the initial activation of P2Y4 leads to
phosphorylation of KCNE1 via PKC [3] and the channel
subunit remains phosphorylated due to inhibition of
phosphatase activity. 2) Activation of P2Y4 leads to local-
ized depletion of phosphatidylinositol-4,5-bisphosphate
(PIP2) in the plasma membrane and to the consequent
deactivation of the PIP2-dependent IKs channel.
Isc is controlled by apical P2Y4 receptors via the protein
kinase C pathway by phosphorylation of the beta subunit
of the IKs channel complex [3] [vida infra]. The sustained
reduction in Isc and the incomplete recovery of Isc after pro-
longed exposure to agonist can both be explained if there
is a decrease of phosphatase activity at the phosphoryla-
tion site. The channel subunit would then be expected to
remain phosphorylated and the effect on Isc would be sus-
tained even with a desensitization of the receptor. How-
ever, dephosphorylation rates have been reported to
increase with elevated intracellular [Ca2+] in olfactory sen-
sory neurons [37], arguing against this hypothesis.
The second explanation is more consistent with our find-
ings. It has been found that activation of receptors (such
as P2Y4) coupled to Gq/11 deplete PIP2 [38] and that IKs
(KCNQ1/KCNE1) activity is controlled by PIP2 [39]. In
fact, the time course of desensitization of another K+ chan-
nel by phenylephrine induced depletion of PIP2 via α1-
adrenergic receptors is similar to the secondary effects
seen here [38].
Physiological significance
Purinergic receptors have been identified on the apical
membrane of many of the cells forming the border of the
cochlear duct [40-42]. Indeed, IKs of strial marginal cells
in the cochlea is inhibited by UTP in much the same way
as the homologous vestibular dark cells [2,17,27],
although the lower potency of agonists on marginal cells
suggests a lower density of receptors. The P2Y4 receptors
can thereby provide the strial marginal cells with an auto-
crine as well as paracrine signaling pathway. Autocrine
signaling is important for these cells since they have no
gap junction communication [43], an unusual occurrence
for epithelial cells. Paracrine signaling is also important in
this organ since the rate of K+ secretion must be adjusted
for variations in K+ efflux during stimulation of the coch-
lea by sound. In fact, the P2 receptors have been proposed
to act as a mechanism to protect the inner ear from noise
damage [44].
Conclusion
The response to purinergic agonists at the apical side of
strial marginal cells was shown here to be functionally
mediated by P2Y4 receptors, previously shown to be
present by immunostaining. The decrease in electrogenic
K+ secretion evoked by agonists was a) initially accompa-
Changes of intracellular Ca2+ concentration Figure 5
Changes of intracellular Ca2+ concentration ([Ca2+]) 
of marginal cell layer in response to three consecutive per-
fusions of UTP (10 µM; 30 s). Top: Time control, no addi-
tional treatments (n = 7); middle: second exposure to UTP in 
the presence of the IP3 receptor inhibitor 2-APB (n = 9); bot-
tom: second exposure to UTP in the absence of bath Ca2+ (n 

















































































Summary recordings of Isc Figure 4
Summary recordings of Isc (Ussing chamber) of strial 
marginal cells during apical perfusion of ATP (10-3 M) for 15 
min. Vertical bars are SEM (not all shown; spaced for clarity; 
n = 6).
ATPCell Communication and Signaling 2005, 3:13 http://www.biosignaling.com/content/3/1/13
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nied by a biphasic increase in intracellular Ca2+ and b)
surprisingly sustained in the continued presence of ago-
nist. The sustained decrease in K+  secretion was best
explained by rapid-onset phosphorylation of KCNE1
channel subunit and a slower-onset of regulation by
depletion of plasma membrane PIP2. Impaired PIP2 and
IKs interaction was recently shown to be the basis of sev-
eral mutations causing long QT syndrome, a genetic dis-




Gerbils (4–5 week old females) were anesthetized by
injection of sodium pentobarbital (50 mg/kg, i.p.) and
the temporal bones were removed. The method for dis-
secting strial marginal cell epithelium from the cochlear
lateral wall was described previously [1]. Dissected epithe-
lia were either transferred to a micro-Ussing chamber for
measurement of the equivalent short circuit current (Isc),
to a perfusion chamber for [Ca2+] measurement or were
frozen in liquid nitrogen within 10 min of death for
reverse transcription-polymerase chain reaction (RT-
PCR). All procedures conformed to protocols approved by
the Institutional Animal Care and Use Committee.
Short-circuit current measurements
The micro-Ussing chamber for inner ear tissues has been
described previously [3]. Briefly, the diameter of the aper-
ture separating the apical and basolateral side half-cham-
bers was 80 µm and each side was continuously perfused
independently at 37°C with an exchange of solution
accomplished within 1 s. Isc was measured with a 4-wire
epithelial current clamp and recorded with a computer
data acquisition system with 16 bits resolution. Samples
were acquired at 32 Hz and decimated by a factor of 10.
Perfusion changes were planned and carefully timed so
that experiments from each experimental series could be
averaged (Figures 1 &4). Results were analyzed and plot-
ted using Origin software (OriginLab, Northampton,
MA).
In one series of experiments (Figure 3), the relative Isc was
measured with a vibrating probe as described previously
[46]. Briefly, the lateral cochlear wall with stria vascularis
was mounted in a perfusion chamber on the stage of an
inverted microscope (Nikon TE-300) and continuously
perfused with the same solution used for the micro-Uss-
ing chamber at 37°C. The Isc relative to the initial control
value was monitored by vibrating a platinum-iridium
wire microelectrode coated with Pt-black on the tip. The
probe was positioned 20–30 µm from the apical surface of
the epithelium. The bath references were 26-gauge Pt-
black electrodes. The probe tip was vibrated in the range
of 200–400 Hz over an excursion of about 20 µm. Vibra-
tion between two positions within the line of current flow
yields voltages in the low nanovolt range that correspond
to current flow through the resistive physiological saline
[47]. The output of the probe amplifier was recorded with
ASET software (Science Wares, East Falmouth, MA).
Although the single perfusate reached the entire stria vas-
cularis, it was determined that brief changes of solution
(≤30 s) effectively reached only the apical surface; the
extremely tight junctions of the basal cell layer restricted
diffusion of large molecules such as agonists and antago-
nists to the interior of the stria and to the basolateral
membrane of marginal cells [1].
Chemicals and solutions
In all experiments, both sides of the epithelium were per-
fused with a solution containing (in mM) NaCl 150,
KH2PO4 0.4, K2HPO4 1.6, MgCl2 1, CaCl2 0.7, glucose 5,
pH 7.4. All experimental agents were dissolved in this
solution immediately before use. Suramin was purchased
from Calbiochem (San Diego, CA) and adenosine 5'-tri-
Gel electrophoresis Figure 6
Gel electrophoresis of reverse transcription-polymerase 
chain reaction (RT-PCR) products from gerbil stria vascula-
ris. Gene-specific primers were used for detection of tran-
scripts for segments of P2Y2 and P2Y4. +, Reactions 
performed in the presence of reverse transcriptase; -, reac-
tions performed in the absence of reverse transcriptase. 
Position of the bands for the expected lengths of the RT-PCR 
products [447 bp, P2Y4; 301 bp, P2Y2] are indicated and a 
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phosphate, 2-aminoethoxy diphenyl borate (2-APB), uri-
dine 5'-triphosphate, uridine 5'-diphosphate (UDP),
diadenosine tetraphosphate (Ap4A) and hexokinase from
Sigma-Aldrich (St. Louis, MO). The 2-APB was predis-
solved in DMSO and used at a final DMSO concentration
of 0.1%.
Intracellular Ca2+ measurements
Calcium was measured as described previously [48].
Briefly, stria vascularis was incubated for 20 min with the
indicator dye 5 µM fluo-4-AM at 37°C (Molecular Probes,
Eugene, OR) and mounted in the superfusion chamber on
the stage of an inverted microscope (Diaphot, Nikon).
The stria vascularis was folded into a loop with the mar-
ginal cell layer on the outside surface. An optical section
of the marginal cells was observed and the recording slit,
which defined the field of the Ca2+ measurement, was
restricted to this cell layer.
The preparation was alternately illuminated at 600 and
488 nm (Deltascan, Photon Technology International,
South Brunswick, N.J.). The fluorescence signal was
detected by a photon-counter (Photon Technology Inter-
national) at a rate of 4 Hz. Changes in the emission inten-
sity were taken as measures of changes in intracellular
Ca2+ ([Ca2+]i). The drift of signal due to leakage of dye
from the cells was linearly subtracted.
Reverse transcription-polymerase chain reaction (RT-
PCR)
Transcripts for P2Y2 and P2Y4 were assayed by RT-PCR
using methods previously described for extraction of total
RNA, DNase I treatment, PCR amplification, subcloning,
and sequencing [14]. First strand cDNA synthesis was also
performed as described previously [14] with the exception
that 25 pmoles of random hexamers were used to prime
the RNA. The sequence of the primers was based on the
known sequences in the coding region of the rat, mouse
and human receptors. P2Y2  primers: sense, 5'-GCT-
TCAACGAGGACTTCAAGTA(C/T)GTGC-3'; anti-sense,
5'-AGGTGAGGAAGAGGATGCTGCAGTAG-3'. P2Y4 prim-
ers: sense, 5'-CCAGAGGAGTTTGACCACTA-3'; anti-sense,
5'-CACCAAGGCCAGGGAGGA-3'. The primers were
expected to yield RT-PCR products of 301 base pairs (bp)
for P2Y2 and 447 bp for P2Y4 which were cloned and
sequenced (GenBank accession numbers: P2Y2,
AF313448; P2Y4, AF313447).
The PCR mixture was incubated as follows: 1 denatura-
tion cycle for 5 min at 98°C; 40 amplification cycles con-
sisting of denaturation for 45 sec at 95°C, annealing for
45 sec at 58°C, and extension for 45 sec at 72°C; and one
extension cycle for 7 min at 72°C. PCR products were ana-
lyzed by horizontal electrophoresis in 2.0% agarose gels
and visualized by ethidium bromide.
Statistics
Data are expressed as the mean ± S.E.M. (n = number of
tissues) of the Isc and concentration-response curves from
changes in Isc were normalized to the response to 1 mM
ATP. The Student's t-test of paired samples was used to
determine statistical significance and increases or
decreases in Isc were considered significant for P < 0.05.
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